Carcinoma of the female urethra: combined iridium Ir 192 interstitial and external beam radiotherapy.
Three female patients (mean age 55) with carcinoma of the urethra were treated with combined external beam irradiation (4,000 to 5,000 rads) and interstitial irradiation with iridium Ir 192 (2,700 to 3,000 rads) applied with a modified Syed-Neblett template. Two patients are alive with no evidence of disease at 27 and 37 months. One patient died of a second primary tumor at 30 months, without histologic evidence of the original urethral neoplasm. No patient had significant complications of therapy. This treatment regimen is effective for selected women with urethral carcinoma.
D000230:Adenocarcinoma / Q000532:radiotherapy*; D001918:Brachytherapy; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy*; D002295:Carcinoma, Transitional Cell / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D007495:Iridium / Q000627:therapeutic use*; D008875:Middle Aged; D011868:Radioisotopes / Q000627:therapeutic use*; D011882:Radiotherapy, High-Energy; D014523:Urethral Neoplasms / Q000532:radiotherapy*
D011868:Radioisotopes; D007495:Iridium